| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Medigen Biotechnology Corp (TWO: 3176)
3176 Technical Analysis
4
| As on 7th Nov 2025 3176 STOCK Price closed @ 31.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 36.92 & Strong Sell for SHORT-TERM with Stoploss of 43.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
3176STOCK Price
| Open | 28.75 | Change | Price | % |
| High | 31.30 | 1 Day | 2.25 | 7.83 |
| Low | 28.75 | 1 Week | 1.45 | 4.91 |
| Close | 31.00 | 1 Month | 2.40 | 8.39 |
| Volume | 877436 | 1 Year | -11.00 | -26.19 |
| 52 Week High 46.65 | 52 Week Low 23.65 | ||||
TWO Taiwan Most Active Stocks
| 1815 | 75.00 | -6.25% |
| 8088 | 46.80 | 9.99% |
| 8096 | 53.50 | -3.08% |
| 5498 | 25.50 | -0.39% |
| 8111 | 66.50 | -1.63% |
| 6274 | 380.00 | -4.40% |
| 8054 | 127.50 | 2.41% |
| 5371 | 91.50 | -3.89% |
| 5289 | 456.00 | 0.22% |
| 6548 | 41.45 | -0.36% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 3176 Daily Charts |
3176 Intraday Charts |
Whats New @ Bazaartrend |
3176 Free Analysis |
|
|
3176 Important Levels Intraday
| RESISTANCE | 35.91 |
| RESISTANCE | 34.34 |
| RESISTANCE | 33.36 |
| RESISTANCE | 32.39 |
| SUPPORT | 29.61 |
| SUPPORT | 28.64 |
| SUPPORT | 27.66 |
| SUPPORT | 26.09 |
3176 Forecast November 2025
| 4th UP Forecast | 43.53 |
| 3rd UP Forecast | 39.51 |
| 2nd UP Forecast | 37.03 |
| 1st UP Forecast | 34.54 |
| 1st DOWN Forecast | 27.46 |
| 2nd DOWN Forecast | 24.97 |
| 3rd DOWN Forecast | 22.49 |
| 4th DOWN Forecast | 18.47 |
3176 Weekly Forecast
| 4th UP Forecast | 36.40 |
| 3rd UP Forecast | 34.67 |
| 2nd UP Forecast | 33.60 |
| 1st UP Forecast | 32.53 |
| 1st DOWN Forecast | 29.47 |
| 2nd DOWN Forecast | 28.40 |
| 3rd DOWN Forecast | 27.33 |
| 4th DOWN Forecast | 25.60 |
3176 Forecast2025
| 4th UP Forecast | 78.31 |
| 3rd UP Forecast | 63.14 |
| 2nd UP Forecast | 53.76 |
| 1st UP Forecast | 44.38 |
| 1st DOWN Forecast | 17.62 |
| 2nd DOWN Forecast | 8.24 |
| 3rd DOWN Forecast | -1.14 |
| 4th DOWN Forecast | -16.31 |
Medigen Biotechnology Corp ( TWO Taiwan Symbol : 3176 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
3176 Business Profile
Medigen Biotechnology Corp. focuses on the development of therapies for liver diseases and cancers in Taiwan. It offers cell therapies, such as MAGICELL-NK, which are natural killer cells; and MAGICELL-GDT, which are T cells. The company develops PI-88 (MUPAFOSTAT), which has completed Phase II clinical trial for use as an adjuvant therapy for HCC after curative surgery; and Phase III trial for the adjuvant treatment of patients with hepatitis virus related hepatocellular carcinoma after surgical resection. It also provides OBP-301 that is in a Phase I clinical trials for the treatment of esophageal cancer, and Phase II clinical trials for the treatment of esophageal and gastric cancer. In addition, the company develops human native mAbs for therapeutic applications related to infectious diseases; and molecular diagnostics, vaccine, and generic drugs. Medigen Biotechnology Corp. was founded in 1999 and is headquartered in Taipei, Taiwan. Address: No.3, Park Street, Taipei, Taiwan, 11503
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service